For: | Wu W, Yang JL, Wang YL, Wang H, Yao M, Wang L, Gu JJ, Cai Y, Shi Y, Yao DF. Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting NF-κB gene transcription. World J Hepatol 2016; 8(23): 985-993 [PMID: 27621764 DOI: 10.4254/wjh.v8.i23.985] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v8/i23/985.htm |
Number | Citing Articles |
1 |
Christian Ramos-Peñafiel, Irma Olarte-Carrillo, Rafael Cerón-Maldonado, Etta Rozen-Fuller, Juan Julio Kassack-Ipiña, Guillermo Meléndez-Mier, Juan Collazo-Jaloma, Adolfo Martínez-Tovar. Effect of metformin on the survival of patients with ALL who express high levels of the ABCB1 drug resistance gene. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1620-6
|
2 |
Zhaolin Chen, Cheng Huang, Taotao Ma, Ling Jiang, Liqin Tang, Tianlu Shi, Shantang Zhang, Lei Zhang, Pengli Zhu, Jun Li, Aizong Shen. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells. Phytomedicine 2018; 43: 37 doi: 10.1016/j.phymed.2018.03.040
|
3 |
Jialiang Wang, Yifan Lian, Yurong Gu, Hongbo Wang, Lin Gu, Yanlin Huang, Liang Zhou, Yuehua Huang. Synergistic effect of farnesyl transferase inhibitor lonafarnib combined with chemotherapeutic agents against the growth of hepatocellular carcinoma cells. Oncotarget 2017; 8(62): 105047 doi: 10.18632/oncotarget.22086
|
4 |
Yoo Jin Na, Eun Sang Yu, Dae Sik Kim, Dae-Hee Lee, Sang Cheul Oh, Chul Won Choi. Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells. The Korean Journal of Internal Medicine 2021; 36(Suppl 1): S196 doi: 10.3904/kjim.2019.336
|
5 |
Zhi Chen, Nobuhiro Nishimura, Takayuki Okamoto, Koichiro Wada, Kohji Naora. Molecular Mechanism of Matrine fromSophora alopecuroidesin the Reversing Effect of Multi-Anticancer Drug Resistance in K562/ADR Cells. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/1269532
|
6 |
Kaizhen Wang, Kuojun Zhang, Xiangyu Zhang, Dong Chen, Sheng Jiang. Recent Insights of Metformin on Hepatocellular Carcinoma (HCC). Mini-Reviews in Medicinal Chemistry 2023; 23(11): 1154 doi: 10.2174/1389557522666220623150717
|
7 |
Chengxiang Zhang, Heng Qin, Rui Zheng, Yubang Wang, Ting Yan, Fei Huan, Yang Han, Weicheng Zhu, Lulu Zhang. A new approach for Alzheimer's disease treatment through P-gp regulation via ibuprofen. Pathology - Research and Practice 2018; 214(11): 1765 doi: 10.1016/j.prp.2018.08.011
|
8 |
Jose J.G. Marin, Oscar Briz, Elisa Herraez, Elisa Lozano, Maitane Asensio, Silvia Di Giacomo, Marta R. Romero, Luis M. Osorio-Padilla, Ana I. Santos-Llamas, Maria A. Serrano, Carolina Armengol, Thomas Efferth, Rocio I.R. Macias. Molecular bases of the poor response of liver cancer to chemotherapy. Clinics and Research in Hepatology and Gastroenterology 2018; 42(3): 182 doi: 10.1016/j.clinre.2017.12.006
|
9 |
Zeting Yuan, Xin Liang, Yueping Zhan, Ziyuan Wang, Jian Xu, Yanyan Qiu, Jie Wang, Yijun Cao, Van-Minh Le, Hai-Trieu Ly, Jianhua Xu, Wei Li, Peihao Yin, Ke Xu. Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer. British Journal of Cancer 2020; 122(9): 1342 doi: 10.1038/s41416-020-0783-0
|
10 |
Qilai Cheng, Shanshan Zhang, Bing Zhong, Zhixi Chen, Fang Peng. Asiatic acid re-sensitizes multidrug-resistant A549/DDP cells to cisplatin by down regulating long non-coding RNA metastasis associated lung adenocarcinoma transcript 1/β-catenin signaling. Bioengineered 2022; 13(5): 12972 doi: 10.1080/21655979.2022.2079302
|
11 |
Juan-Juan Gu, Min Yao, Jie Yang, Yin Cai, Wen-Jie Zheng, Li Wang, Deng-Bing Yao, Deng-Fu Yao. Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis. World Journal of Gastroenterology 2017; 23(2): 256-264 doi: 10.3748/wjg.v23.i2.256
|
12 |
Qingyun Zhang, Jian Kong, Shuying Dong, Wenlei Xu, Wenbing Sun. Metformin exhibits the anti-proliferation and anti-invasion effects in hepatocellular carcinoma cells after insufficient radiofrequency ablation. Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0418-6
|
13 |
Ming Sui, Hairong Yang, Mingqi Guo, Wenle Li, Zheng Gong, Jing Jiang, Peiling Li. Cajanol Sensitizes A2780/Taxol Cells to Paclitaxel by Inhibiting the PI3K/Akt/NF-κB Signaling Pathway. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.783317
|
14 |
María Paula Ceballos, Juan Pablo Rigalli, Lucila Inés Ceré, Mariana Semeniuk, Viviana Alicia Catania, María Laura Ruiz. ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma. Current Medicinal Chemistry 2019; 26(7): 1224 doi: 10.2174/0929867325666180105103637
|
15 |
Yingbin Huang, Guangyu Chen, Yang Wang, Rui He, Jun Du, Xingyuan Jiao, Qiang Tai. Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2018; 503(2): 1035 doi: 10.1016/j.bbrc.2018.06.113
|
16 |
Aneta Rogalska, Barbara Bukowska, Agnieszka Marczak. Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells. Toxicology in Vitro 2018; 47: 48 doi: 10.1016/j.tiv.2017.11.001
|
17 |
Milad Iranshahy, Ramin Rezaee, Gholamreza Karimi. Hepatoprotective activity of metformin: A new mission for an old drug?. European Journal of Pharmacology 2019; 850: 1 doi: 10.1016/j.ejphar.2019.02.004
|
18 |
Zhimin Tang, Nan Tang, Shanshan Jiang, Yangjinming Bai, Chenxi Guan, Wansi Zhang, Shipan Fan, Yonghong Huang, Hui Lin, Ying Ying. The Chemosensitizing Role of Metformin in Anti-Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry 2021; 21(8): 949 doi: 10.2174/1871520620666200918102642
|
19 |
Aneta Rogalska, Agnieszka Marczak. Therapeutic potential of patupilone in epithelial ovarian cancer and future directions. Life Sciences 2018; 205: 38 doi: 10.1016/j.lfs.2018.04.058
|
20 |
Xue Jiang, Hor-Yue Tan, Shanshan Teng, Yau-Tuen Chan, Di Wang, Ning Wang. The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma. Cancers 2019; 11(5): 647 doi: 10.3390/cancers11050647
|
21 |
Yina Zhang, Jiajia Shao, Shuangshuang Li, Yanning Liu, Min Zheng. The Crosstalk Between Regulatory Non-Coding RNAs and Nuclear Factor Kappa B in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.775250
|
22 |
Yang Q. Xia, Ren J. Hua, Chen Juan, Zhou H. Zhong, Cheng S. Tao, Ren Fang, He Lin, Gong Rui, Chen Yong. SIRT6 Depletion Sensitizes Human Hepatoma Cells to Chemotherapeutics by Downregulating MDR1 Expression. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00194
|
23 |
Jeff Yat‐Fai Chung, Max Kam‐Kwan Chan, Philip Chiu‐Tsun Tang, Alex Siu‐Wing Chan, Justin Shing‐Yin Chung, Xiao‐Ming Meng, Ka‐Fai To, Hui‐Yao Lan, Kam‐Tong Leung, Patrick Ming‐Kuen Tang. AANG: A natural compound formula for overcoming multidrug resistance via synergistic rebalancing the TGF‐β/Smad signalling in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2021; 25(20): 9805 doi: 10.1111/jcmm.16928
|
24 |
Yun Soo Jeong, Thuy Giang Lam, Seho Jeong, Sang-Gun Ahn. Metformin Derivative HL156A Reverses Multidrug Resistance by Inhibiting HOXC6/ERK1/2 Signaling in Multidrug-Resistant Human Cancer Cells. Pharmaceuticals 2020; 13(9): 218 doi: 10.3390/ph13090218
|